Dergiler / Journal of Immunology and Clinical Microbiology / 2026 / Cilt: 1 Sayı: 2

Immunology of Osteoporosis: A Short-Review

Sayfa
48–52
Yayın Tarihi
2016-09-30
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This review aims to provide a short overview of osteoimmunology in osteoporosis .

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The osteoporosis pathogenesis is multifactorial and the immune system has an important role.
📊
Temel Bulgular & Veri:Free radicals and the proteins or lipids that become glycated after exposure to sugars that may be related with bone resorption and inflammation.
💡
Sonuç & Katkı:This review aims to provide a short overview of osteoimmunology in osteoporosis .
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Osteoporosis · osteoimmunology · bone

Abstract

The osteoporosis pathogenesis is multifactorial and the immune system has an important role. Free radicals and the proteins or lipids that become glycated after exposure to sugars that may be related with bone resorption and inflammation. It is now recognized that the receptor activator of NF-κB ligand (RANKL) has a major role at the bone resorbing. The physiological receptor of the biological activity of RANKL is managed by osteoprotegerin (OPG). The balance of RANKL and OPG in physiological bone turnover may control the bone density and pathological conditions. This review aims to provide a short overview of osteoimmunology in osteoporosis .

🔖

Bu Makaleye Atıf Yap

Subaşı, V. (2016). Immunology of Osteoporosis: A Short-Review. Journal of Immunology and Clinical Microbiology, Cilt: 1 Sayı: 2, 48–52. https://doi.org/10.5455/jicm.6.20160514

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Yeter A, Kavuncu V, Evcik FD, Demirdal ÜS, Subaşı V, Çakır T. Evalution the effects of raloxifene and risedronate on serum biochemical markers. Türk Osteoporoz derg 2014; 20: 110-116.
  2. Pietschmann P, Mechtcheriakova D, Meshcheryakova A, Föger-Samwald U, Ellinger I. Immunology of Osteoporosis: A Mini-Review. Gerontology 2016; 62: 128-137.
  3. Arron JR, Choi Y. Bone versus immune system. Nature 2000; 408: 535-536.
  4. Rauner M, Sipos W, Thiele S, Pietschmann P. Advances in osteoimmunology: pathophysiologic concepts and treatment opportunities. Int Arch Allergy Immunol 2013; 160: 114-125.
  5. Blázquez-Medela AM, López-Novoa JM, Martínez-Salgado C. Osteoprotegerin and diabetes-associated pathologies. Curr Mol Med 2011; 5: 401-416.
  6. Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 2007; 9(Suppl 1): S1. doi:10.1186/ar2165.